Clinical Trial Update: Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD) [NA]

View source ↗

Summary

A completed clinical trial evaluating an herbal formula aligned with traditional Chinese medicine syndromes for coronary heart disease patients after PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• Herbal formula corresponding to syndrome for CHD post-PCI

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Coronary Heart Disease | NA | Status: COMPLETED